FIGS, Inc. (NYSE: FIGS) is a Consumer Cyclical company in the Apparel - Manufacturers industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 43.71 | EPS (ttm) | 0.24 | Insider Own | - | Shs Outstand | 167.05M | Perf Week | 12.51% |
| Market Cap | 1.79B | Forward P/E | 33.42 | EPS next Y | 0.32 | Insider Trans | -0.50% | Shs Float | 151.66M | Perf Month | 6.47% |
| Enterprise Value | 1.77B | PEG | 0.01 | EPS next Q | - | Inst Own | - | Short Float | 13.13% | Perf Quarter | -28.48% |
| Income | 40.75M | P/S | 2.68 | EPS this Y | 19.26% | Inst Trans | - | Short Ratio | 5.99 | Perf Half Y | -4.46% |
| Sales | 666.10M | P/B | 4.14 | EPS next Y | 22.01% | ROA | 7.21% | Short Interest | 19.92M | Perf YTD | -5.81% |
| Book/sh | - | P/C | 36.55 | EPS next 5Y | - | ROE | 9.69% | 52W High | 17.77 -38.79% | Perf Year | 62.37% |
| Cash/sh | - | P/FCF | 45.31 | EPS past 3/5Y | 19.98% -9.33% | ROIC | 6.84% | 52W Low | 6.17 76.28% | Perf 3Y | 45.98% |
| Dividend Est. | - | EV/EBITDA | 28.50 | Sales past 3/5Y | 7.64% 19.13% | Gross Margin | 66.10% | Volatility | 5.18% 4.91% | Perf 5Y | -73.08% |
| Dividend TTM | - | EV/Sales | 2.66 | EPS Y/Y TTM | 1356.95% | Oper. Margin | 6.43% | ATR (14) | 0.55 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.65 | Sales Y/Y TTM | 19.96% | Profit Margin | 6.10% | RSI (14) | 53.18 | Recom | 2.60 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.39 | EPS Q/Q | - | SMA20 | 5.98% | Beta | 1.02 | Target Price | 18.00 |
| Payout | 0.00% | Debt/Eq | 0.14 | Sales Q/Q | 28.00% | SMA50 | -3.17% | Rel Volume | 1.51 | Prev Close | 10.70 |
| Employees | 388 | LT Debt/Eq | 0.12 | Earnings | Aug 06 | SMA200 | -9.14% | Avg Volume | 3.37M | Price | 10.88 |
| IPO Date | May 27, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 108.70% 4.41% | Net Debt/EBITDA | -0.22 | Volume | 5,089,092 | Change | 1.68% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Apr-28-26 | Reiterated | Keybanc | Overweight | $19 |
| Mar-20-26 | Upgrade | Oppenheimer | Perform → Outperform | |
| Mar-12-26 | Reiterated | Telsey Advisory Group | Market Perform | $7.00 → $17 |
| Feb-27-26 | Upgrade | Keybanc | Sector Weight → Overweight | |
| Jan-30-26 | Reiterated | Goldman Sachs | Sell | $7.50 |
| Jan-13-26 | Reiterated | Morgan Stanley | Equal Weight | $11 → $8.00 |
| Jan-06-26 | Reiterated | Barclays | Equal Weight | $7.00 → $11 |
| Dec-10-25 | Reiterated | BTIG | Buy | $9.00 → $15 |
| Oct-14-25 | Initiated | BTIG | Buy | $9.00 |
| Aug-09-24 | Reiterated | Telsey Advisory Group | Market Perform | $21 → $7.00 |
FIGS, Inc. functions as a direct-to-consumer enterprise specializing in healthcare apparel and lifestyle merchandise across the United States. The company innovates and distributes a comprehensive selection of medical uniforms, complemented by a diverse array of non-scrub items. These offerings span functional pieces like lab coats, under-scrubs, compression socks, footwear, and masks, extending to activewear, loungewear, and outerwear such as performance leggings, sports bras, various tops (including super-soft pima cotton options), vests, and jackets. Customers can access and purchase FIGS' products directly through its integrated digital platform, which encompasses both its official website and mobile application. Founded in 2013, FIGS, Inc. is headquartered in Santa Monica, California.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 667 | 631 | 556 | 546 | 506 | 420 | 263 | 110 | |
| Cost of Goods Sold Incl. D&A | 226 | 211 | 180 | 169 | 151 | 118 | 73 | 31 | |
| Gross Profit | 440 | 420 | 376 | 377 | 354 | 301 | 190 | 79 | |
| Selling, General and Administrative Excl. Other | 277 | 289 | 373 | 343 | 317 | 290 | 132 | 80 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 119 | 93 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating Income | 43 | 38 | 2 | 34 | 38 | 11 | 58 | 0 | |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 9 | 9 | 12 | 7 | 1 | -1 | 0 | 0 | |
| Net Income Before Taxes | 51 | 47 | 14 | 41 | 39 | 10 | 58 | 0 | |
| Income Taxes | 11 | 13 | 12 | 18 | 18 | 19 | 8 | 0 | |
| Consolidated Net Income | 41 | 34 | 3 | 23 | 21 | -10 | 50 | 0 | |
| Net Income From Continuing Operations | 41 | 34 | 3 | 23 | 21 | -10 | 50 | 0 | |
| Net Income | 41 | 34 | 3 | 23 | 21 | -10 | 50 | 0 | |
| EPS (Recurring) | 0.24 | 0.21 | 0.02 | 0.13 | 0.13 | -0.06 | 0.31 | 0.00 | |
| EPS (Basic, Before Extraordinaries) | 0.24 | 0.21 | 0.02 | 0.13 | 0.13 | -0.06 | 0.31 | 0.00 | |
| EPS (Diluted) | 0.22 | 0.19 | 0.02 | 0.12 | 0.11 | -0.06 | 0.31 | 0.00 | |
| EBITDA | 62 | 56 | 21 | 44 | 41 | 12 | 59 | 0 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 49.45 | 59.79 | 409.93 | 57.92 | 61.18 | — | — | — | |
| Price To Sales Ratio | 2.71 | 2.93 | 1.88 | 2.14 | 2.19 | 10.76 | — | — | |
| Gross Margin | 65.97 | 66.56 | 67.63 | 69.05 | 69.96 | 71.67 | 72.24 | 71.82 | |
| Operating Margin | 6.45 | 6.02 | 0.36 | 6.23 | 7.51 | 2.62 | 22.05 | 0.00 | |
| Net Margin | 6.15 | 5.39 | 0.54 | 4.21 | 4.15 | -2.38 | 19.01 | 0.00 | |
| Shares Outstanding | 166 | 163 | 169 | 168 | 165 | 164 | 161 | 161 | |
| Market Capitalization | 1,806 | 1,852 | 1,046 | 1,168 | 1,110 | 4,520 | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Oughtred Sarah | Chief Financial Officer | May 04 '26 | Sale | 14.33 | 23,597 | 338,237 | 1,129,791 | May 06 |
| Hasson Heather L. | Executive Chairman | May 04 '26 | Sale | 14.33 | 32,385 | 464,203 | 1,433,807 | May 06 |
| Oughtred Sarah | Chief Financial Officer | Apr 02 '26 | Sale | 14.44 | 10,872 | 156,980 | 1,153,388 | Apr 06 |
| Spear Catherine Eva | Chief Executive Officer | Apr 02 '26 | Sale | 14.44 | 62,335 | 900,049 | 1,794,964 | Apr 06 |
| Hasson Heather L. | Executive Chair | Mar 03 '26 | Sale | 16.85 | 556,327 | 9,375,334 | 1,251,967 | Mar 03 |
| Hasson Heather L. | Executive Chair | Mar 02 '26 | Option Exercise | 1.24 | 1,213,336 | 1,499,336 | 2,465,303 | Mar 03 |
| Oughtred Sarah | Chief Financial Officer | Feb 05 '26 | Sale | 10.56 | 22,690 | 239,606 | 821,500 | Feb 09 |
| Hasson Heather L. | Executive Chair | Feb 05 '26 | Sale | 10.56 | 22,874 | 241,549 | 1,251,967 | Feb 09 |
| Oughtred Sarah | Chief Financial Officer | Jan 07 '26 | Sale | 11.50 | 10,515 | 120,927 | 834,830 | Jan 08 |
| Spear Catherine Eva | Chief Executive Officer | Jan 06 '26 | Sale | 11.38 | 49,734 | 565,918 | 1,857,299 | Jan 08 |
| Oughtred Sarah | Chief Financial Officer | Nov 04 '25 | Sale | 7.39 | 22,745 | 168,015 | 845,345 | Nov 06 |
| Hasson Heather L. | Executive Chair | Nov 04 '25 | Sale | 7.39 | 23,356 | 172,528 | 1,274,841 | Nov 06 |
| Oughtred Sarah | Chief Financial Officer | Oct 03 '25 | Sale | 7.36 | 9,968 | 73,364 | 868,090 | Oct 06 |
| Spear Catherine Eva | Chief Executive Officer | Oct 02 '25 | Sale | 6.88 | 62,213 | 428,081 | 1,907,033 | Oct 06 |
| Spear Catherine Eva | Chief Executive Officer | Aug 13 '25 | Sale | 6.88 | 65,866 | 453,158 | 1,969,246 | Aug 14 |